Cargando…
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study
To assess challenges with daily oral antiretroviral therapy (ART), we analyzed data for 2389 participants in the 2019 Positive Perspectives survey of people living with HIV in 25 countries. ART-related challenges reported included difficulty swallowing pills (33.1% [790/2389]); stress from daily dos...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936969/ https://www.ncbi.nlm.nih.gov/pubmed/33026574 http://dx.doi.org/10.1007/s10461-020-03055-1 |
_version_ | 1783661297494130688 |
---|---|
author | de los Rios, Patricia Okoli, Chinyere Castellanos, Erika Allan, Brent Young, Benjamin Brough, Garry Muchenje, Marvelous Eremin, Anton Corbelli, Giulio Maria McBritton, Marta Hardy, W. David Van de Velde, Nicolas |
author_facet | de los Rios, Patricia Okoli, Chinyere Castellanos, Erika Allan, Brent Young, Benjamin Brough, Garry Muchenje, Marvelous Eremin, Anton Corbelli, Giulio Maria McBritton, Marta Hardy, W. David Van de Velde, Nicolas |
author_sort | de los Rios, Patricia |
collection | PubMed |
description | To assess challenges with daily oral antiretroviral therapy (ART), we analyzed data for 2389 participants in the 2019 Positive Perspectives survey of people living with HIV in 25 countries. ART-related challenges reported included difficulty swallowing pills (33.1% [790/2389]); stress from daily dosing routine (33.3% [795/2389]); bad memories from daily intake of HIV medication (35.1%[839/2389]), and concern “that having to take pills every day means a greater chance of revealing my HIV status to others” (37.9% [906/2389]). Individuals who felt empowered by daily oral dosing [“taking my pill(s) every day reassures me that my HIV is being kept under control”] had 69% higher odds of optimal overall health (AOR 1.69, 95% CI 1.40–2.04). Conversely, odds of optimal overall health were lower among those who felt daily pill intake “limits my day-to-day life” (AOR 0.53, 95% CI 0.44–0.64). These findings show that there is need for increased flexibility of ART delivery to meet diverse patient needs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10461-020-03055-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7936969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-79369692021-03-28 Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study de los Rios, Patricia Okoli, Chinyere Castellanos, Erika Allan, Brent Young, Benjamin Brough, Garry Muchenje, Marvelous Eremin, Anton Corbelli, Giulio Maria McBritton, Marta Hardy, W. David Van de Velde, Nicolas AIDS Behav Original Paper To assess challenges with daily oral antiretroviral therapy (ART), we analyzed data for 2389 participants in the 2019 Positive Perspectives survey of people living with HIV in 25 countries. ART-related challenges reported included difficulty swallowing pills (33.1% [790/2389]); stress from daily dosing routine (33.3% [795/2389]); bad memories from daily intake of HIV medication (35.1%[839/2389]), and concern “that having to take pills every day means a greater chance of revealing my HIV status to others” (37.9% [906/2389]). Individuals who felt empowered by daily oral dosing [“taking my pill(s) every day reassures me that my HIV is being kept under control”] had 69% higher odds of optimal overall health (AOR 1.69, 95% CI 1.40–2.04). Conversely, odds of optimal overall health were lower among those who felt daily pill intake “limits my day-to-day life” (AOR 0.53, 95% CI 0.44–0.64). These findings show that there is need for increased flexibility of ART delivery to meet diverse patient needs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10461-020-03055-1) contains supplementary material, which is available to authorized users. Springer US 2020-10-07 2021 /pmc/articles/PMC7936969/ /pubmed/33026574 http://dx.doi.org/10.1007/s10461-020-03055-1 Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper de los Rios, Patricia Okoli, Chinyere Castellanos, Erika Allan, Brent Young, Benjamin Brough, Garry Muchenje, Marvelous Eremin, Anton Corbelli, Giulio Maria McBritton, Marta Hardy, W. David Van de Velde, Nicolas Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study |
title | Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study |
title_full | Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study |
title_fullStr | Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study |
title_full_unstemmed | Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study |
title_short | Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study |
title_sort | physical, emotional, and psychosocial challenges associated with daily dosing of hiv medications and their impact on indicators of quality of life: findings from the positive perspectives study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936969/ https://www.ncbi.nlm.nih.gov/pubmed/33026574 http://dx.doi.org/10.1007/s10461-020-03055-1 |
work_keys_str_mv | AT delosriospatricia physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT okolichinyere physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT castellanoserika physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT allanbrent physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT youngbenjamin physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT broughgarry physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT muchenjemarvelous physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT ereminanton physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT corbelligiuliomaria physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT mcbrittonmarta physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT hardywdavid physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy AT vandeveldenicolas physicalemotionalandpsychosocialchallengesassociatedwithdailydosingofhivmedicationsandtheirimpactonindicatorsofqualityoflifefindingsfromthepositiveperspectivesstudy |